These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3183355)

  • 21. [Activities of antithrombin III and heparin cofactor II in patients with pathologic blood coagulation conditions].
    Hirokawa S; Kaji T; Tazawa K; Fujimaki M; Hayashi T; Niiya K; Sakuragawa N
    Rinsho Ketsueki; 1992 Mar; 33(3):281-7. PubMed ID: 1578630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of ethanol challenge on serum glycoproteins in alcoholic and non-alcoholic liver disease.
    Cobden I; Matthewson K; Carr WP; Dick WC; Record CO
    Alcohol Alcohol; 1987; 22(3):257-63. PubMed ID: 2441717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum procollagen III peptide in alcoholic and other chronic liver diseases.
    Bell H; Raknerud N; Orjasaeter H; Haug E
    Scand J Gastroenterol; 1989 Dec; 24(10):1217-22. PubMed ID: 2602904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laboratory determination of heparin cofactor II.
    Ezenagu LC; Brandt JT
    Arch Pathol Lab Med; 1986 Dec; 110(12):1149-51. PubMed ID: 3778142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retinol and retinyl esters in patients with alcoholic liver disease.
    Bell H; Nilsson A; Norum KR; Pedersen LB; Raknerud N; Rasmussen M
    J Hepatol; 1989 Jan; 8(1):26-31. PubMed ID: 2921501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated levels of thrombin-heparin cofactor II complex in plasma from patients with disseminated intravascular coagulation.
    Andersson TR; Sie P; Pelzer H; Aamodt LM; Nustad K; Abildgaard U
    Thromb Res; 1992 Jun; 66(5):591-8. PubMed ID: 1523613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin cofactor II in adults and infants with thrombosis and DIC.
    Chuansumrit A; Manco-Johnson MJ; Hathaway WE
    Am J Hematol; 1989 Jun; 31(2):109-13. PubMed ID: 2525333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of heparin or dermatan sulfate to thrombin is essential for the sulfated polysaccharide-accelerated inhibition of thrombin by heparin cofactor II.
    Yamagishi R; Koide T; Sakuragawa N
    FEBS Lett; 1987 Dec; 225(1-2):109-12. PubMed ID: 3691797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical detection of the hepatic lesion of pericentral sclerosis in chronic alcoholics.
    Kaku Y; Hasumura Y; Takeuchi J
    Gut; 1982 Mar; 23(3):215-20. PubMed ID: 7068046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hereditary heparin cofactor II deficiency and the risk of development of thrombosis.
    Bertina RM; van der Linden IK; Engesser L; Muller HP; Brommer EJ
    Thromb Haemost; 1987 Apr; 57(2):196-200. PubMed ID: 3603411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin cofactor II deficiency in renal allograft recipients: no correlation with the development of thrombosis.
    Toulon P; Moulonguet-Doleris L; Costa JM; Aiach M
    Thromb Haemost; 1991 Jan; 65(1):20-4. PubMed ID: 2024235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma levels of soluble tumor necrosis factor receptors p55 and p75 in patients with alcoholic liver disease of increasing severity.
    Naveau S; Emilie D; Balian A; Grangeot-Keros L; Borotto E; Portier A; Giraud V; Capron F; Galanaud P; Chaput JC
    J Hepatol; 1998 May; 28(5):778-84. PubMed ID: 9625312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Standardization of the laboratory method for antithrombin activity measurement].
    Okajima K
    Rinsho Byori; 2002 Mar; 50(3):283-6. PubMed ID: 11985057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin cofactor II assay. Elimination of heparin and antithrombin-III effects.
    Nakhleh R; Vogt JM; Edson JR
    Am J Clin Pathol; 1988 Mar; 89(3):353-8. PubMed ID: 3348170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alcoholic liver disease in Punjab.
    Roy K; Chawla LS; Sabharwal BD; Singh K; Whig J
    Indian J Gastroenterol; 1985 Jul; 4(3):161-2. PubMed ID: 3848411
    [No Abstract]   [Full Text] [Related]  

  • 36. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay.
    Fukui H; Brauner B; Bode JC; Bode C
    J Hepatol; 1991 Mar; 12(2):162-9. PubMed ID: 2050995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation.
    Tran TH; Duckert F
    Thromb Haemost; 1984 Oct; 52(2):112-6. PubMed ID: 6395434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Plasma glycoprotein variations in alcoholic hepatopathies after an oral ethanol overload: preliminary study].
    Ibarra de la Rosa I; Blanco FJ; Caballero Plasencia AM; Mora Lara JR
    Rev Esp Enferm Apar Dig; 1985 Apr; 67(4):309-15. PubMed ID: 4001525
    [No Abstract]   [Full Text] [Related]  

  • 39. Decreased endotoxin-binding capacity of whole blood in patients with alcoholic liver disease.
    Schäfer C; Greiner B; Landig J; Feil E; Schütz ET; Bode JC; Bode C
    J Hepatol; 1997 Mar; 26(3):567-73. PubMed ID: 9075664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-activity relationships of heparin. Independence of heparin charge density and antithrombin-binding domains in thrombin inhibition by antithrombin and heparin cofactor II.
    Hurst RE; Poon MC; Griffith MJ
    J Clin Invest; 1983 Sep; 72(3):1042-5. PubMed ID: 6688430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.